AEON Biopharma, Inc.
AEON
$0.40
-$0.0093-2.27%
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Net Income | 2.08M | -6.17M | 164.11M | -118.02M | -26.24M |
| Total Depreciation and Amortization | 23.00K | 25.00K | 24.00K | 25.00K | 24.00K |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -6.02M | 3.77M | -170.14M | 109.30M | 16.65M |
| Change in Net Operating Assets | 3.30M | -577.00K | -2.11M | 96.00K | -1.45M |
| Cash from Operations | -621.00K | -2.96M | -8.12M | -8.60M | -11.02M |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -- | -- | -- | -- | -- |
| Total Debt Issued | 0.00 | 0.00 | 10.00M | 5.00M | 0.00 |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 97.00K | 50.00K | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 97.00K | 50.00K | 10.00M | 5.00M | 0.00 |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -524.00K | -2.91M | 1.88M | -3.60M | -11.02M |
